.JPG)
SIOUX FALLS, S.D. (KELO AM) - Avera announced today its joining the Worldwide Innovative Networking Consortium that focuses on personalized cancer care using genomic analysis.
Dr. Brian Leyland-Jones says greater success against cancer is achieved through worldwide collaboration.
He says the approach to cancer so far has been population medicine-treatments based on what has shown to be most effective for people with a certain type of cancer.
Leyland-Jones says WIN gives patients access to innovative clinical trials and drugs.